Skip to content

The therapeutic effect of contralateral acupuncture combined with repeated transcranial magnetic stimulation on motor function in stroke patients during the recovery period

The therapeutic effect of contralateral acupuncture combined with repeated transcranial magnetic stimulation on motor function in stroke patients during the recovery period

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083951
Enrollment
Unknown
Registered
2024-05-08
Start date
2024-05-13
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral apoplexy

Interventions

control group:The control group received acupuncture treatment on the affected side combined with rTMS treatment on the basis of routine rehabilitation treatment for 4 weeks. (1) Acupuncture plan: The
Experimental group:The control group was treated with staged giant needling combined with rTMS on the basis of routine rehabilitation treatment, which first needled the healthy side for 2 weeks, and t

Sponsors

Shanghai Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) 2 weeks to 6 months after the onset of stroke; (2) First onset, unilateral lesion, located in a unilateral subcortical stroke (basal nucleus, thalamus, internal capsule, corona radiata), with motor dysfunction on one side of the upper limb; (3) Voluntarily participate in this clinical trial, and either the individual or their family member signs an informed consent form;

Exclusion criteria

Exclusion criteria: (1) Hemiplegia caused by non cerebrovascular diseases such as traumatic brain injury, brain tumor, and postoperative brain surgery; (2) Individuals with severe organ failure such as heart, lung, liver, and kidney; (3) Individuals with a history of stroke and/or residual limb dysfunction; (4) Poor compliance and failure to follow medical advice for treatment; (5) Individuals with unilateral neglect or blindness; (6) Patients with acupuncture intolerance; Excluding pregnant women; (7) Individuals with a tendency towards bleeding; Patients with brain tumors, arterial malformations, and venous malformations; Individuals with severe heart valve disease, cardioembolic conditions, etc; (8) Patients whose bodies contain metal devices such as pacemakers, stents, and cochlear implants that are not suitable for transcranial magnetic stimulation; (9) There are metal hardware in close contact with the discharge coil, such as cochlear implants, internal pulse generators, or drug pumps. (10) There are electrodes made of silver and gold in the skull, as well as metal brain implants. (11) Patients with electronic components (such as IPG located in the neck or torso) within a distance of less than 10cm from the TMS coil (such as pacemakers, vagus nerve stimulation systems, and spinal cord stimulators) are prohibited from using electronic components within the body. (12) Patients with a distance of less than 10cm between the implanted pulse generator for deep brain stimulation and the transcranial magnetic stimulation coil are prohibited; (13) Having a history of epileptic seizures, frequent headaches, tinnitus, and drug abuse, using anesthetic analgesics in the past two weeks.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment-Upper Extremities;

Secondary

MeasureTime frame
modified Barthel Index;Lovett muscle strength grading;d potential (MEP) cortical latency, amplitude, and central motor conduction time;

Countries

People's Republic of China

Contacts

Public ContactWang Jiening

Shanghai University of Traditional Chinese Medicine Affiliated Seventh People's Hospital

drwjn0606@sina.com+86 139 0163 4270

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026